黄芪注射液对乳腺癌患者辅助化疗后胃肠道不良反应及营养状态的影响
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R737.9

基金项目:


Effect of Astragalus Injection in Assisting Post-chemotherapy Gastrointestinal Side Effects and Nutritional Status in Patients with Breast Cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探究黄芪注射液对乳腺癌患者辅助化疗后胃肠道不良反应和营养状态的影响。方法:将化疗后乳腺癌患者83例按随机数字表法分为2组,对照组41例在化疗的基础上予以安慰剂进行辅助治疗,观察组42例在化疗的基础上予以黄芪注射液进行辅助治疗。对比2组患者治疗后胃肠道不良反应、毒性反应和生活质量以及治疗前后的营养状态的变化情况。结果:对照组不良反应率为36.59%,观察组为9.52%,2组比较,差异有统计学意义(P<0.05)。经治疗,2组白细胞(WBC)比较,差异无统计学意义(P>0.05)。2组血红蛋白(Hb)、血小板计数(BPC)比较,差异有统计学意义(P<0.05)。观察组治疗后肱三头肌褶厚度、腰围、体质量优于对照组,差异有统计学意义(P<0.05)。观察组精神健康、情感功能、生理功能、心理状态、活动能力、躯体疼痛、社会功能、整体健康评分明显优于对照组,差异有统计学意义(P<0.05)。结论:黄芪注射液对乳腺癌患者辅助化疗后,可以有效减少患者胃肠道不良反应和毒性反应,维持患者的营养状态,提高生活质量。

    Abstract:

    To explore the effect of astragalus injection in assisting post-chemotherapy gastrointestinal side effects and nutritional status in patients with breast cancer.Methods:Divided 83 cases of post-chemotherapy patients with breast cancer into two groups randomly,41 cases in the control group and 42 cases in the observation group.The control group received pIacebo based on chemotherapy,while the observation group received astragalus injection based on chemotherapy.Compared the changes in gastrointestinal side effects,toxic reactions and quality of life after treatment as well as nutritional status before and after treatment of patients in both groups.Results:The incidence of adverse reactions was 36.59%in the control group and 9.52%in the observation group,difference being significant(P < 0.05).After treatment,comparing WBC in both groups,there was no significant difference being found(P>0.05).Comparing Hb and BPC in both groups,there was significant difference being found(P < 0.05).After treatment,the skinfold thickness of triceps,waist circumference,body mass in the observation group were better than those in the control group,difference being significant(P < 0.05).The scores of mental health,emotional function,physiological function,mental state,activity ability,bodily pain,social function and ove rall health in the observation group were significantly better than those in the control group,difference being significant(P<0.05).Conclusion:Astragalus injection in assisting chemotherapy for breast cancer can effectively reduce gastrointestinal side effects and toxic reactions of patients,sustain their nutritional status and promote the quality of life.

    参考文献
    相似文献
    引证文献
引用本文

汪东杰,汪丽艳,黄炜.黄芪注射液对乳腺癌患者辅助化疗后胃肠道不良反应及营养状态的影响[J].新中医,2019,51(10):128-131

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-10-11
  • 出版日期: